Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Vaxcyte, Inc.(PCVX) | 1,372,425 | 1,425,470 | +53,045 | $79.75M | $82.86M | 26.92% | +$3.11M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 1,355,892 | 1,265,283 | -90,609 | $31.94M | $33.18M | 10.78% | +$1.23M |
| Trevi Therapeutics, Inc.(TRVI) | 1,553,726 | 1,742,672 | +188,946 | $18.54M | $32.50M | 10.56% | +$13.96M |
| Avalyn Pharmaceuticals Inc | 0 | 966,792 | +966,792 | $0 | $31.83M | 10.34% | +$31.83M |
| Evommune, Inc.(EVMN) | 1,926,943 | 1,926,943 | 0 | $44.30M | $25.61M | 8.32% | -$18.69M |
| MapLight Therapeutics, Inc.(MPLT) | 611,447 | 611,446 | -1 | $12.43M | $21.91M | 7.12% | +$9.48M |
| Oculis Holding AG(OCS) | 1,680,283 | 1,506,250 | -174,033 | $44.68M | $20.89M | 6.79% | -$23.79M |
| BioAge Labs, Inc.(BIOA) | 653,374 | 653,374 | 0 | $11.43M | $16.01M | 5.20% | +$4.59M |
| Immunome, Inc.(IMNM) | 732,512 | 732,512 | 0 | $16.02M | $15.52M | 5.04% | -$498.1K |
| Zenas BioPharma, Inc.(ZBIO) | 591,991 | 490,766 | -101,225 | $11.57M | $12.46M | 4.05% | +$882.2K |
| Avalo Therapeutics, Inc.(AVTX) | 295,933 | 434,033 | +138,100 | $4.42M | $8.02M | 2.61% | +$3.60M |
| Rallybio Corporation(RLYB) | 300,579 | 300,579 | 0 | $2.70M | $4.81M | 1.56% | +$2.11M |
| Recursion Pharmaceuticals, Inc.CL A(RXRX) | 595,518 | 595,518 | 0 | $1.83M | $2.19M | 0.71% | +$357.3K |
| Bolt Biotherapeutics Inc | 42,581 | 0 | -42,581 | $172.0K | $0 | — | -$172.0K |